EKINOPS (EKI.PA) Fundamental Analysis & Valuation

EPA:EKI • FR0011466069

Current stock price

1.689 EUR
-0.02 (-1%)
Last:

This EKI.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. EKI.PA Profitability Analysis

1.1 Basic Checks

  • In the past year EKI has reported negative net income.
  • EKI had a positive operating cash flow in the past year.
  • EKI had positive earnings in 4 of the past 5 years.
  • In the past 5 years EKI always reported a positive cash flow from operatings.
EKI.PA Yearly Net Income VS EBIT VS OCF VS FCFEKI.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M 15M 20M

1.2 Ratios

  • EKI has a worse Return On Assets (-4.50%) than 65.63% of its industry peers.
  • Looking at the Return On Equity, with a value of -7.96%, EKI is in line with its industry, outperforming 40.63% of the companies in the same industry.
Industry RankSector Rank
ROA -4.5%
ROE -7.96%
ROIC N/A
ROA(3y)1.57%
ROA(5y)1.92%
ROE(3y)2.47%
ROE(5y)3.22%
ROIC(3y)N/A
ROIC(5y)N/A
EKI.PA Yearly ROA, ROE, ROICEKI.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10 -15

1.3 Margins

  • In the last couple of years the Operating Margin of EKI has remained more or less at the same level.
  • EKI has a better Gross Margin (54.73%) than 68.75% of its industry peers.
  • EKI's Gross Margin has been stable in the last couple of years.
  • EKI does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 54.73%
OM growth 3Y14.72%
OM growth 5Y0.77%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.19%
GM growth 5Y0.54%
EKI.PA Yearly Profit, Operating, Gross MarginsEKI.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. EKI.PA Health Analysis

2.1 Basic Checks

  • EKI does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, EKI has more shares outstanding
  • The number of shares outstanding for EKI has been increased compared to 5 years ago.
  • The debt/assets ratio for EKI has been reduced compared to a year ago.
EKI.PA Yearly Shares OutstandingEKI.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
EKI.PA Yearly Total Debt VS Total AssetsEKI.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

  • EKI has an Altman-Z score of 1.01. This is a bad value and indicates that EKI is not financially healthy and even has some risk of bankruptcy.
  • With a Altman-Z score value of 1.01, EKI perfoms like the industry average, outperforming 40.63% of the companies in the same industry.
  • The Debt to FCF ratio of EKI is 3.98, which is a good value as it means it would take EKI, 3.98 years of fcf income to pay off all of its debts.
  • EKI's Debt to FCF ratio of 3.98 is in line compared to the rest of the industry. EKI outperforms 50.00% of its industry peers.
  • EKI has a Debt/Equity ratio of 0.28. This is a healthy value indicating a solid balance between debt and equity.
  • EKI has a Debt to Equity ratio (0.28) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.28
Debt/FCF 3.98
Altman-Z 1.01
ROIC/WACCN/A
WACC7.61%
EKI.PA Yearly LT Debt VS Equity VS FCFEKI.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M 100M

2.3 Liquidity

  • EKI has a Current Ratio of 1.95. This is a normal value and indicates that EKI is financially healthy and should not expect problems in meeting its short term obligations.
  • With a decent Current ratio value of 1.95, EKI is doing good in the industry, outperforming 62.50% of the companies in the same industry.
  • EKI has a Quick Ratio of 1.56. This is a normal value and indicates that EKI is financially healthy and should not expect problems in meeting its short term obligations.
  • EKI's Quick ratio of 1.56 is fine compared to the rest of the industry. EKI outperforms 68.75% of its industry peers.
Industry RankSector Rank
Current Ratio 1.95
Quick Ratio 1.56
EKI.PA Yearly Current Assets VS Current LiabilitesEKI.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. EKI.PA Growth Analysis

3.1 Past

  • The earnings per share for EKI have decreased strongly by -871.39% in the last year.
  • EKI shows a small growth in Revenue. In the last year, the Revenue has grown by 1.56%.
  • The Revenue has been growing slightly by 4.71% on average over the past years.
EPS 1Y (TTM)-871.39%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-134.84%
Revenue 1Y (TTM)1.56%
Revenue growth 3Y4.35%
Revenue growth 5Y4.71%
Sales Q2Q%-0.52%

3.2 Future

  • Based on estimates for the next years, EKI will show a small growth in Earnings Per Share. The EPS will grow by 4.26% on average per year.
  • The Revenue is expected to grow by 9.21% on average over the next years. This is quite good.
EPS Next Y-50%
EPS Next 2Y-15.67%
EPS Next 3Y4.26%
EPS Next 5YN/A
Revenue Next Year-14.3%
Revenue Next 2Y-3.78%
Revenue Next 3Y0.9%
Revenue Next 5Y9.21%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
EKI.PA Yearly Revenue VS EstimatesEKI.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 50M 100M 150M 200M
EKI.PA Yearly EPS VS EstimatesEKI.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.2 -0.2 -0.4

More info and screens

Find the best growth stocksShow best growing peers

4

4. EKI.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • EKI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • The Price/Forward Earnings ratio is 15.68, which indicates a correct valuation of EKI.
  • Based on the Price/Forward Earnings ratio, EKI is valued cheaper than 81.25% of the companies in the same industry.
  • EKI is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.19, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 15.68
EKI.PA Price Earnings VS Forward Price EarningsEKI.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, EKI is valued cheaper than 96.88% of the companies in the same industry.
  • 87.50% of the companies in the same industry are more expensive than EKI, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 4.64
EV/EBITDA 4.37
EKI.PA Per share dataEKI.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-15.67%
EPS Next 3Y4.26%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. EKI.PA Dividend Analysis

5.1 Amount

  • EKI does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

EKI.PA Fundamentals: All Metrics, Ratios and Statistics

EKINOPS

EPA:EKI (3/27/2026, 4:42:43 PM)

1.689

-0.02 (-1%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryCommunications Equipment
Earnings (Last)03-10
Earnings (Next)N/A
Inst Owners41.77%
Inst Owner ChangeN/A
Ins Owners13.65%
Ins Owner ChangeN/A
Market Cap45.65M
Revenue(TTM)117.37M
Net Income(TTM)-8.97M
Analysts77.78
Price Target3.55 (110.18%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-13%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-20.21%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-5.26%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 15.68
P/S 0.39
P/FCF 4.64
P/OCF 2.71
P/B 0.4
P/tB 0.91
EV/EBITDA 4.37
EPS(TTM)-0.33
EYN/A
EPS(NY)0.11
Fwd EY6.38%
FCF(TTM)0.36
FCFY21.56%
OCF(TTM)0.62
OCFY36.85%
SpS4.34
BVpS4.17
TBVpS1.86
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -4.5%
ROE -7.96%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 54.73%
FCFM 8.39%
ROA(3y)1.57%
ROA(5y)1.92%
ROE(3y)2.47%
ROE(5y)3.22%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)4.58%
ROCE(5y)3.87%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y14.72%
OM growth 5Y0.77%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.19%
GM growth 5Y0.54%
F-Score3
Asset Turnover0.59
Health
Industry RankSector Rank
Debt/Equity 0.28
Debt/FCF 3.98
Debt/EBITDA 3.02
Cap/Depr 43.61%
Cap/Sales 5.95%
Interest Coverage N/A
Cash Conversion 160.62%
Profit Quality N/A
Current Ratio 1.95
Quick Ratio 1.56
Altman-Z 1.01
F-Score3
WACC7.61%
ROIC/WACCN/A
Cap/Depr(3y)65.04%
Cap/Depr(5y)56.44%
Cap/Sales(3y)6.79%
Cap/Sales(5y)5.99%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-871.39%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-134.84%
EPS Next Y-50%
EPS Next 2Y-15.67%
EPS Next 3Y4.26%
EPS Next 5YN/A
Revenue 1Y (TTM)1.56%
Revenue growth 3Y4.35%
Revenue growth 5Y4.71%
Sales Q2Q%-0.52%
Revenue Next Year-14.3%
Revenue Next 2Y-3.78%
Revenue Next 3Y0.9%
Revenue Next 5Y9.21%
EBIT growth 1Y-1122.3%
EBIT growth 3Y19.71%
EBIT growth 5Y5.52%
EBIT Next Year129.42%
EBIT Next 3Y53.68%
EBIT Next 5YN/A
FCF growth 1Y1325.65%
FCF growth 3Y13.36%
FCF growth 5Y13.72%
OCF growth 1Y106.32%
OCF growth 3Y18.46%
OCF growth 5Y16.59%

EKINOPS / EKI.PA Fundamental Analysis FAQ

What is the fundamental rating for EKI stock?

ChartMill assigns a fundamental rating of 3 / 10 to EKI.PA.


Can you provide the valuation status for EKINOPS?

ChartMill assigns a valuation rating of 4 / 10 to EKINOPS (EKI.PA). This can be considered as Fairly Valued.


How profitable is EKINOPS (EKI.PA) stock?

EKINOPS (EKI.PA) has a profitability rating of 3 / 10.


How financially healthy is EKINOPS?

The financial health rating of EKINOPS (EKI.PA) is 4 / 10.